JOSE PAGAN: Open Payments
NPI 1578545901 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,289 in 140 payments from 15 companies in 2025. Trend: 2023 $2,020 · 2024 $2,553 · 2025 $2,289
Food & beverage: $2,289
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $530 |
| Alkermes, Inc. | 32 | $357 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $296 |
| Lundbeck LLC | 14 | $217 |
| Teva Pharmaceuticals USA, Inc. | 10 | $202 |
| Vanda Pharmaceuticals Inc. | 16 | $199 |
| E.R. Squibb & Sons, L.L.C. | 9 | $137 |
| Neurocrine BioSciences, Inc. | 5 | $114 |
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| Supernus Pharmaceuticals, Inc. | 3 | $67 |
Products named: CAPLYTA, ARISTADA, TRINTELLIX, REXULTI, AUSTEDO XR, FANAPT, COBENFY, INGREZZA.
Industry payments across TX — which companies pay providers there.
